- Home
- OMCC vs OCEA Comparison
OMCC vs OCEA Comparison
Compare OMCC & OCEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCC
- OCEA
- Stock Information
- Founded
- OMCC N/A
- OCEA 2019
- Country
- OMCC
- OCEA United States
- Employees
- OMCC 7
- OCEA N/A
- Industry
- OMCC
- OCEA Biotechnology: Pharmaceutical Preparations
- Sector
- OMCC
- OCEA Health Care
- Exchange
- OMCC NYSE
- OCEA Nasdaq
- Market Cap
- OMCC 45.3M
- OCEA 36.4M
- IPO Year
- OMCC N/A
- OCEA N/A
- Fundamental
- Price
- OMCC $6.02
- OCEA $1.00
- Analyst Decision
- OMCC
- OCEA
- Analyst Count
- OMCC 0
- OCEA 0
- Target Price
- OMCC N/A
- OCEA N/A
- AVG Volume (30 Days)
- OMCC N/A
- OCEA 68.2K
- Earning Date
- OMCC N/A
- OCEA 11-12-2024
- Dividend Yield
- OMCC N/A
- OCEA N/A
- EPS Growth
- OMCC N/A
- OCEA N/A
- EPS
- OMCC N/A
- OCEA N/A
- Revenue
- OMCC N/A
- OCEA N/A
- Revenue This Year
- OMCC N/A
- OCEA N/A
- Revenue Next Year
- OMCC N/A
- OCEA N/A
- P/E Ratio
- OMCC N/A
- OCEA N/A
- Revenue Growth
- OMCC N/A
- OCEA N/A
- 52 Week Low
- OMCC N/A
- OCEA $0.52
- 52 Week High
- OMCC N/A
- OCEA $7.79
- Technical
- Relative Strength Index (RSI)
- OMCC N/A
- OCEA 52.95
- Support Level
- OMCC N/A
- OCEA $0.89
- Resistance Level
- OMCC N/A
- OCEA $1.10
- Average True Range (ATR)
- OMCC 0.00
- OCEA 0.08
- MACD
- OMCC 0.00
- OCEA 0.01
- Stochastic Oscillator
- OMCC 0.00
- OCEA 36.00
About OMCC OLD MARKET CAPITAL CORPORATION
Old Market Capital Corp formerly Nicholas Financial Inc is a specialized consumer finance company. It is engaged in acquiring and servicing automobile finance installment contracts for purchases of used and new automobiles and light trucks. It also originates direct consumer loans and sells consumer-finance-related products. The majority of its revenue comes from Interest and fee income.
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.